Active Pharmaceutical Ingredient Chemical Modification

0 votes
asked Jun 23, 2022 in Cell Tracking by HelenS. (1,580 points)


Industry estimates indicate that over 80% of new chemical entities exhibit low solubility, low bioavailability, and/or low or inconsistent dissolution rates. Effectively addressing these drug solubility, bioavailability, and dissolution rate issues is critical to advancing compound development and providing patients with the therapeutic benefits needed for pharmaceutical products. The Enhanced Bioavailability services provided by CD Formulation make us a leader in addressing issues of low solubility, low bioavailability and dissolution rates. Our end-to-end enhancement solutions combine the full capability to take a compound from concept to commercialization, minimizing project complexity, timelines and risk.



Active Pharmaceutical Ingredient Chemical Modification

Please log in or register to answer this question.

Welcome to Bioimagingcore Q&A, where you can ask questions and receive answers from other members of the community.